John Graham
John Graham leads the Zuellig Pharma Executive Management team. His vision is to transform Zuellig Pharma into an indispensable strategic partner to those engaged in the Asian healthcare ecosystem, by providing a full spectrum of innovative and integrated solutions across the healthcare value chain.
John brings with him over 30 years of experience in biotech, pharmaceuticals, and healthcare consulting. He has previously held various leadership positions including the role of CEO Invida, where he successfully positioned the business as a leading commercialization specialist in the region. Invida was acquired by A. Menarini where John continued as CEO of Menarini Asia Pacific until 2015, transforming the business into a regional pharma company.
John started his career with Aventis, where he spent 18 years in various operational and global leadership positions including regional responsibilities in Latin America, Head of Global Diabetes, and Global VP of New Products. Following that, he was Managing Director of Genzyme's operations in Germany and Switzerland before building up a Life Sciences Advisory Practice at Ernst & Young.
John brings with him over 30 years of experience in biotech, pharmaceuticals, and healthcare consulting. He has previously held various leadership positions including the role of CEO Invida, where he successfully positioned the business as a leading commercialization specialist in the region. Invida was acquired by A. Menarini where John continued as CEO of Menarini Asia Pacific until 2015, transforming the business into a regional pharma company.
John started his career with Aventis, where he spent 18 years in various operational and global leadership positions including regional responsibilities in Latin America, Head of Global Diabetes, and Global VP of New Products. Following that, he was Managing Director of Genzyme's operations in Germany and Switzerland before building up a Life Sciences Advisory Practice at Ernst & Young.